Who are Akoyabio's investors?

Akoyabio's investors include aMoon, Telegraph Hill Partners.

How much funding has Akoyabio raised?

Akoyabio has disclosed $33.5M raised across 2 rounds.

Where is Akoyabio headquartered?

Akoyabio is headquartered in Billerica, US.

Akoyabio

Acquired

Billerica, US · Founded 2015 · 2 known investors

Biotech Healthtech Medical Devices

Founders & leadership

Brian McKelligonExecutive

Garry NolanNamed on SEC filing

Matthew WinklerNamed on SEC filing

Board

Rob Hart inBoard directorPartner at Telegraph Hill Partners

Robert SheplerinBoard directorPartner Emeritus at Telegraph Hill Partners

Thomas Raffin inBoard directorPartner Emeritus, M.D. at Telegraph Hill Partners

Investors · 2

aMoonRa'anana

Telegraph Hill PartnersSan Francisco · $2M – $8M

Reported raises · per SEC filings

Form D private placements

$33.5M disclosed across 2 rounds · 2017–2018

▶$24.5MraisedOct 2018 · 6 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Garry NolanDirector
Thomas RaffinDirector
Matthew WinklerDirector
Brian McKelligonExecutive Officer, Director
Robert SheplerDirector
Rob HartExecutive Officer

Offering amount: $25.5M
Amount sold: $24.5M
First sale: Sep 2018
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$9MraisedJul 2017 · 6 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Garry NolanDirector
Rob HartExecutive Officer
Robert SheplerDirector
Thomas RaffinDirector
Matthew WinklerDirector
Brian McKelligonExecutive Officer

Offering amount: $9M
Amount sold: $9M
First sale: Jul 2017
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Quanterix35 shared keywordsQuanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention. The company serves the precision healthcare and life sciences research market with biomarker detection tools.

Leinco10 shared keywordsLeinco Technologies manufactures antibodies and proteins, offering both large- and small-scale IVD antibody and protein production along with CDMO services for scientists in life sciences discovery, biopharmaceutical, and diagnostics segments. Its reagents support research in areas such as cancer, infectious diseases, and immunology.

Companies competing with Akoyabio for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2018	$149.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who are Akoyabio's investors?: Akoyabio's investors include aMoon, Telegraph Hill Partners.
How much funding has Akoyabio raised?: Akoyabio has disclosed $33.5M raised across 2 rounds.
Where is Akoyabio headquartered?: Akoyabio is headquartered in Billerica, US.